{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:53:14Z","timestamp":1793245994977,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073458"],"award-info":[{"award-number":["82073458"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173424"],"award-info":[{"award-number":["82173424"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830096"],"award-info":[{"award-number":["81830096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974476"],"award-info":[{"award-number":["81974476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012269","name":"Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"publisher","award":["2021RC4013"],"award-info":[{"award-number":["2021RC4013"]}],"id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B20017"],"award-info":[{"award-number":["B20017"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2020YFA0112904"],"award-info":[{"award-number":["2020YFA0112904"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012176","name":"Project 211","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.phrs.2022.106318","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T11:25:40Z","timestamp":1655551540000},"page":"106318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Topical VX-509 attenuates psoriatic inflammation through the STAT3\/FABP5 pathway in keratinocytes"],"prefix":"10.1016","volume":"182","author":[{"given":"Bei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehong","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2022.106318_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis--epidemiology and clinical spectrum","volume":"26","author":"Christophers","year":"2001","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106318_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","article-title":"The psychosocial burden of psoriasis","volume":"6","author":"Kimball","year":"2005","journal-title":"Am. J. Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/jid.2011.259","article-title":"Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands","volume":"132","author":"Morizane","year":"2012","journal-title":"J. Investig. Dermatol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106318_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","article-title":"Antimicrobial peptides in the pathogenesis of psoriasis","volume":"39","author":"Morizane","year":"2012","journal-title":"J. Dermatol."},{"key":"10.1016\/j.phrs.2022.106318_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106215","article-title":"Bruton\u2019s tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23\/IL-17A in innate immune cells","volume":"80","author":"Nadeem","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2022.106318_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173088","article-title":"Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells","volume":"877","author":"Al-Harbi","year":"2020","journal-title":"Eur. J. Pharm."},{"issue":"10281","key":"10.1016\/j.phrs.2022.106318_bib7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2022.106318_bib8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2020.09.023","article-title":"Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice","volume":"179","author":"Nadeem","year":"2020","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.phrs.2022.106318_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"13","key":"10.1016\/j.phrs.2022.106318_bib10","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20101102","article-title":"Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons","volume":"207","author":"Gregorio","year":"2010","journal-title":"J. Exp. Med."},{"issue":"9997","key":"10.1016\/j.phrs.2022.106318_bib11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2022.106318_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of Psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.phrs.2022.106318_bib13","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7927.1","article-title":"Recent advances in understanding psoriasis","volume":"5","author":"Eberle","year":"2016","journal-title":"F1000Res"},{"issue":"7130","key":"10.1016\/j.phrs.2022.106318_bib14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.phrs.2022.106318_bib15","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1468-3083.2009.03372.x","article-title":"Scalp psoriasis: European consensus on grading and treatment algorithm","volume":"23","author":"Ortonne","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"10","key":"10.1016\/j.phrs.2022.106318_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1346-8138.2010.00871.x","article-title":"Clinical course of guttate psoriasis: long-term follow-up study","volume":"37","author":"Ko","year":"2010","journal-title":"J. Dermatol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106318_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2022.106318_bib18","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":".9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106318_bib19","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib20","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028548","article-title":"Targeting IL-10 family cytokines for the treatment of human diseases","volume":"11","author":"Wang","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.phrs.2022.106318_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Wolk","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106318_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-009-0457-0","article-title":"IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not","volume":"vol. 87","author":"Wolk","year":"2009","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/exd.13467","article-title":"Interleukin-17 alters the biology of many cell types involved in the genesis of psoriasis, systemic inflammation and associated comorbidities","volume":"27","author":"Krueger","year":"2018","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jdermsci.2011.11.011","article-title":"Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-beta and STAT-3 activating cytokines, IFN-gamma, IL-6, and IL-22","volume":"65","author":"Honma","year":"2012","journal-title":"J. Dermatol. Sci."},{"issue":"7","key":"10.1016\/j.phrs.2022.106318_bib26","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jid.2019.01.014","article-title":"IL-17 and IL-22 Promote Keratinocyte Stemness in the Germinative Compartment in Psoriasis\\","volume":"vol. 139","author":"Ekman","year":"2019","journal-title":"J. Investig. Dermatol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106318_bib27","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0959-8049(03)00232-6","article-title":"Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers","volume":"39","author":"Grossi","year":"2003","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amjoto.2005.07.018","article-title":"Correlation between proliferating cell nuclear antigen and p53 protein expression and 5-year survival rate in nasopharyngeal carcinoma","volume":"27","author":"Wang","year":"2006","journal-title":"Am. J. Otolaryngol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","article-title":"Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation","volume":"11","author":"Thatikonda","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.39463","article-title":"Decernotinib: a next-generation jakinib","volume":"68","author":"Gadina","year":"2016","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.39473","article-title":"VX-509 (Decernotinib), an oral selective JAK-3 inhibitor, in combination with methotrexate in patients with rheumatoid arthritis","volume":"68","author":"Genovese","year":"2016","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.38949","article-title":"A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritis","volume":"67","author":"Fleischmann","year":"2015","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.phrs.2022.106318_bib33","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1136\/annrheumdis-2015-208901","article-title":"Efficacy of VX-509 (decernotinib) in combination with a disease-modifying antirheumatic drug in patients with rheumatoid arthritis: clinical and MRI findings","volume":"75","author":"Genovese","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/bj3020363","article-title":"Purification and characterization of the human epidermal fatty acid-binding protein: localization during epidermal cell differentiation in vivo and in vitro","volume":"302","author":"Siegenthaler","year":"1994","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.phrs.2022.106318_bib35","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3892\/or.2012.1922","article-title":"Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma","volume":"28","author":"Jeong","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2022.106318_bib36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopha.2018.12.060","article-title":"Inhibition of spleen tyrosine kinase attenuates psoriasis-like inflammation in mice through blockade of dendritic cell-Th17 inflammation axis","volume":"111","author":"Alzahrani","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.phrs.2022.106318_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.nutr.27.061406.093710","article-title":"The emerging functions and mechanisms of mammalian fatty acid-binding proteins","volume":"28","author":"Storch","year":"2008","journal-title":"Annu. Rev. Nutr."},{"issue":"9","key":"10.1016\/j.phrs.2022.106318_bib38","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.87.9.3484","article-title":"Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related","volume":"87","author":"Berk","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-291X(83)91801-6","article-title":"Studies of oleate binding to rat liver plasma membranes","volume":"112","author":"Stremmel","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"24","key":"10.1016\/j.phrs.2022.106318_bib40","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1021\/bi000314z","article-title":"Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions","volume":"39","author":"Richieri","year":"2000","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.phrs.2022.106318_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/dneu.22314","article-title":"Fatty acid binding protein 7 and n-3 poly unsaturated fatty acid supply in early rat brain development","volume":"76","author":"Maximin","year":"2016","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.phrs.2022.106318_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.plefa.2014.10.001","article-title":"Enterocyte fatty acid-binding proteins (FABPs): different functions of liver and intestinal FABPs in the intestine","volume":"93","author":"Gajda","year":"2015","journal-title":"Prostaglandins Leukot. Ess. Fat. Acids"},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1006\/bbrc.1993.1073","article-title":"Characterization and expression of a novel human fatty acid-binding protein: the epidermal type (E-FABP)","volume":"190","author":"Siegenthaler","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2022.106318_bib44","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00018-002-8490-y","article-title":"New insights into the structure and function of fatty acid-binding proteins","volume":"59","author":"Zimmerman","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phrs.2022.106318_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2017.02.018","article-title":"Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase","volume":"46","author":"Al-Harbi","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106318_bib46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets","volume":"7","author":"Furuhashi","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2022.106318_bib47","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3389\/fimmu.2019.01807","article-title":"Psoriasis: obesity and fatty acids","volume":"10","author":"Kunz","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106318_bib48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.bbalip.2018.06.010","article-title":"Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-kappaB) signaling in cancer cells","volume":"1863","author":"Senga","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"10","key":"10.1016\/j.phrs.2022.106318_bib49","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.4049\/jimmunol.1701416","article-title":"Stearic acid induces CD11c expression in proinflammatory macrophages via epidermal fatty acid binding protein","volume":"200","author":"Zeng","year":"2018","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.phrs.2022.106318_bib50","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2022.106318_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092708","article-title":"Protein tyrosine phosphatases as potential regulators of STAT3 signaling","volume":"vol. 19","author":"Kim","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2022.106318_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092820","article-title":"Nucleus, mitochondrion, or reticulum? STAT3 a La Carte","volume":"19","author":"Avalle","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020603","article-title":"The multifaced role of STAT3 in cancer and its implication for anticancer therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2022.106318_bib55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib56","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.1102224","article-title":"IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice","volume":"188","author":"Van Belle","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2022.106318_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bcp.2016.10.012","article-title":"Psoriatic inflammation enhances allergic airway inflammation through IL-23\/STAT3 signaling in a murine model","volume":"124","author":"Nadeem","year":"2017","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.phrs.2022.106318_bib58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pnpbp.2017.12.015","article-title":"Systemic inflammation in asocial BTBR T(+) tf\/J mice predisposes them to increased psoriatic inflammation","volume":"83","author":"Nadeem","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.phrs.2022.106318_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020331","article-title":"A potential nutraceutical candidate lactucin inhibits adipogenesis through downregulation of JAK2\/STAT3 signaling pathway-mediated mitotic clonal expansion","volume":"9","author":"Wang","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00262-019-02445-2","article-title":"IL-17A promotes fatty acid uptake through the IL-17A\/IL-17RA\/p-STAT3\/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment","volume":"69","author":"Yu","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"32","key":"10.1016\/j.phrs.2022.106318_bib61","doi-asserted-by":"crossref","first-page":"51251","DOI":"10.18632\/oncotarget.9984","article-title":"Iciartin, a novel FASN inhibitor, exerts anti-melanoma activities through IGF-1R\/STAT3 signaling","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2022.106318_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117221","article-title":"Dihydroartemisinin inhibits endothelial cell tube formation by suppression of the STAT3 signaling pathway","volume":"242","author":"Gao","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2022.106318_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BC20090070","article-title":"Signal transducer and activator of transcription 3 (STAT3) regulates adipocyte differentiation via peroxisome-proliferator-activated receptor gamma (PPARgamma)","volume":"102","author":"Wang","year":"2009","journal-title":"Biol. Cell"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:33:43Z","timestamp":1778582023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822002638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":63,"alternative-id":["S1043661822002638"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106318","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical VX-509 attenuates psoriatic inflammation through the STAT3\/FABP5 pathway in keratinocytes","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106318","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106318"}}